MD, FRCP, FRCPath, FFPath
Professor of Transfusion Medicine
Mike Murphy is Professor of Transfusion Medicine at the University of Oxford and is Consultant Haematologist for NHS Blood & Transplant (NHSBT) and the Oxford University Hospitals NHS Foundation Trust. He provides the leadership for the hospital transfusion and immunohaematology services for the Oxford University Hospitals. He qualified at St.Bartholomew's Hospital Medical College, University of London, where he completed his training in haematology and became a Senior Lecturer in Haematology. In 1996, he moved to Oxford. The work done by he and his Oxford colleagues using technology to improve the safety and effectiveness of transfusion practice has won numerous national awards and serves as an exemplar for the NHS Quality, Innovation and Productivity (QIPP) initiative. It was highlighted by Chief Medical Officer in 2015 NIHR Annual Report as foolproof way of ensuring transfusion safety with potential savings of >£50 million/year if implemented across NHS. He is a recipient of the British Blood Transfusion Society's Kenneth Goldsmith Award, and co-founded the NHSBT Clinical Studies Unit, its Systematic Reviews Initiative for transfusion medicine and the Transfusion Evidence Library . He chaired a guideline on blood transfusion for the National Institute for Health and Clinical Excellence (NICE) which was published in November 2015. He is a Board Member and Vice-President of the American Association of Blood Banks. He has received numerous research grants and is the author of more than 250 articles. He is current Chair of the international research group, the BEST Collaborative. He has co-edited all five editions of the textbook Practical Transfusion Medicine.
Maternal and neonatal outcomes of antenatal anemia in a Scottish population: a retrospective cohort study.
Rukuni R. et al, (2016), Acta Obstet Gynecol Scand, 95, 555 - 564
Thrombocytopenia and Platelet Transfusion
Murphy MF. et al, (2016), Rossi's Principles of Transfusion Medicine
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
Estcourt LJ. et al, (2016), Cochrane Database Syst Rev, 3
Spotlight on platelets: summary of BBTS combined special interest group autumn meeting, November 2015.
Murphy MF. et al, (2016), Transfus Med, 26, 8 - 14
Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a U.K. dual centre experience.
Hall S. et al, (2015), Transfus Med, 25, 418 - 423